VYNE Therapeutics Inc. (VYNE)
USD 2.42
(-8.33%)
USD 2.42
(-8.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 424 Thousand | 477 Thousand | 14.75 Million | 20.99 Million | 443 Thousand | 10.64 Million |
| Cost of Revenue | - | - | 3.34 Million | 1.39 Million | 350 Thousand | - |
| Gross Profit | 424 Thousand | 477 Thousand | 11.4 Million | 19.6 Million | 93 Thousand | 10.64 Million |
| Operating Expenses | 29.68 Million | 34.77 Million | 79.43 Million | 133.07 Million | 76.24 Million | 65.17 Million |
| Selling, General and Administrative Expenses | 13.37 Million | 16.38 Million | 54.48 Million | 89.54 Million | 22.48 Million | 12.18 Million |
| Research and Development Expenses | 16.3 Million | 18.38 Million | 24.95 Million | 43.53 Million | 53.76 Million | 52.98 Million |
| Other Expenses | - | 363 Thousand | -135 Thousand | 1.11 Million | - | - |
| Cost and Expenses | 29.68 Million | 34.77 Million | 82.78 Million | 134.46 Million | 76.24 Million | 65.17 Million |
| Operating Income | -29.25 Million | -34.29 Million | -68.03 Million | -113.47 Million | -76.24 Million | -54.53 Million |
| Interest Expense | - | - | 5.61 Million | 4.39 Million | 2.53 Million | 3.09 Million |
| Income Tax Expense | - | 13 Thousand | -448 Thousand | -258 Thousand | -3.23 Million | 3.09 Million |
| Earnings before Tax | -27.87 Million | -33.93 Million | -73.77 Million | -255.82 Million | -73.7 Million | -51.44 Million |
| Net Income | -28.45 Million | -33.94 Million | -73.32 Million | -255.56 Million | -70.46 Million | -51.44 Million |
| Earnings Per Share Basic | -2.77 | -10.65 | -25.65 | -141.90 | -149.48 | -170.94 |
| Earnings Per Share Diluted | -2.77 | -10.65 | -25.65 | -141.90 | -149.48 | -170.94 |
| Weighted Average Shares Outstanding | 10.27 Million | 3.18 Million | 2.85 Million | 1.8 Million | 471.38 Thousand | 300.95 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 10.27 Million | 3.18 Million | 2.85 Million | 1.8 Million | 471.38 Thousand | 300.95 Thousand |
| Gross Margin | 1.00 | 1.00 | 0.77 | 0.93 | 0.21 | 1.00 |
| EBIT Margin | -69.00 | -71.14 | -4.62 | -5.34 | -172.10 | -5.13 |
| Profit Margin | -67.10 | -71.16 | -4.97 | -12.17 | -159.06 | -4.84 |
| EBITDA | -29.25 Million | -34.22 Million | -38.93 Million | -251.09 Million | -94.08 Million | -54.53 Million |
| Earnings Before Tax Margin | -69.00 | -71.90 | -4.61 | -5.41 | -172.10 | -5.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 198 Thousand | 98 Thousand | 76 Thousand | 424 Thousand | 114 Thousand | 135 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 198 Thousand | 98 Thousand | 76 Thousand | 424 Thousand | 114 Thousand | 135 Thousand |
| Operating Expenses | 10.59 Million | 7.47 Million | 6.9 Million | 29.68 Million | 6.34 Million | 10.45 Million |
| Selling, General and Administrative Expenses | 3.28 Million | 3.77 Million | 3.88 Million | - | 3.03 Million | 3.22 Million |
| Research and Development Expenses | 7.3 Million | 3.7 Million | 3.02 Million | - | 3.31 Million | 7.23 Million |
| Other Expenses | 1 Million | 1.13 Million | 680 Thousand | 1.38 Million | 163 Thousand | 280 Thousand |
| Cost and Expenses | 10.59 Million | 7.47 Million | 6.9 Million | 29.68 Million | 6.34 Million | 10.45 Million |
| Operating Income | -10.39 Million | -7.38 Million | -6.83 Million | -29.25 Million | -6.23 Million | -10.31 Million |
| Interest Expense | - | - | 263 Thousand | - | - | - |
| Income Tax Expense | 11 Thousand | 8000.00 | 37 Thousand | 580 Thousand | 513 Thousand | 20 Thousand |
| Earnings before Tax | -9.39 Million | -6.24 Million | -6.15 Million | -27.87 Million | -6.07 Million | -10.03 Million |
| Net Income | -9.39 Million | -6.24 Million | -6.18 Million | -28.45 Million | -6.58 Million | -10.05 Million |
| Earnings Per Share Basic | -0.22 | -0.15 | -0.20 | - | -2.01 | -3.08 |
| Earnings Per Share Diluted | -0.22 | -0.15 | -0.20 | - | -2.01 | -3.08 |
| Weighted Average Shares Outstanding | 42.58 Million | 42.58 Million | 31.05 Million | 10.27 Million | 3.28 Million | 3.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.58 Million | 42.58 Million | 31.05 Million | 10.27 Million | 3.28 Million | 3.27 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -52.51 | -75.31 | -89.89 | - | -54.68 | -76.43 |
| Profit Margin | -47.45 | -63.68 | -81.42 | -67.10 | -57.75 | -74.50 |
| EBITDA | -10.39 Million | -7.38 Million | -6.83 Million | - | -6.23 Million | -10.31 Million |
| Earnings Before Tax Margin | -52.51 | -75.31 | -89.89 | -69.00 | -54.68 | -76.43 |
RYLPF
MDIKF
PRENW
TDSGF
062040
2437